- Home
- FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), 25mM HEPES w/o Glucose, Sodium Pyruvate, Phenol Red: 1X Liquid
FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), 25mM HEPES w/o Glucose, Sodium Pyruvate, Phenol Red: 1X Liquid
FluxMPS™ DCP-DMEMH-GPR1X is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) glucose-free, sodium-pyruvate-free DMEM formulated with 25 mM HEPES, built for metabolic flux analysis, 13C isotope tracing, Warburg-effect research, and organ-on-a-chip applications where carbon source identity must be precisely controlled. A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration. Formulation: [+] L-Glutamine, [+] Sodium Bicarbonate, [+] HEPES, [+] Calcium, [+] Magnesium | [-] Phenol Red, [-] Glucose, [-] Sodium Pyruvate.
- Glucose-free and sodium-pyruvate-free — add D-glucose, U-13C6-glucose, galactose, fructose, or another carbon source at the exact concentration your protocol requires
- 25 mM HEPES (pKa 7.3 at 37°C) provides supplemental buffering alongside the formulation's sodium bicarbonate — see the CO2 note in Technical Specifications for the recommended incubator setting
- Quadruple-stage filtration: 0.1 µm prefilter I → 0.04 µm final filter I → 0.1 µm prefilter II → 0.04 µm final filter II (polish)
- Endotoxin release specification < 0.05 EU/mL (LAL, USP 85), tested per manufacturing batch, not per unit
- Phenol red not added to this formulation — reduces optical background for imaging-based assays
- Manufactured under an ISO 13485:2016 quality management system; final QC at Diagnocine, Totowa, NJ
- Formulation: [+] L-Glutamine, [+] Sodium Bicarbonate, [+] HEPES, [+] Calcium, [+] Magnesium | [-] Phenol Red, [-] Glucose, [-] Sodium Pyruvate
- Custom glucose concentrations, carbon sources, and nutrient modifications available on request — support@diagnocine.com
- GlucoseNot included — researcher-defined
- HEPES25 mM (5958 mg/L), pKa 7.3 at 37°C
- Formulation[+] L-Glutamine, [+] Sodium Bicarbonate, [+] HEPES, [+] Calcium, [+] Magnesium | [-] Phenol Red, [-] Glucose, [-] Sodium Pyruvate
- AppearanceOrange-colored, clear solution
- pH (USP <791>)7.4
- Osmolality (USP <785>)310–350 mOsm/kg H2O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2
- Storage2–8°C, protect from light
- Shelf Life12 months from date of manufacture, unopened
Available pack sizes: 500 mL, 1000 mL
When carbon source control is the experiment
Standard DMEM contains a fixed glucose concentration that cannot be changed without switching media entirely. FluxMPS™ glucose-free, pyruvate-free DMEM + HEPES gives you a clean base formulation where every carbon source is added fresh, at the identity and concentration you choose — while ultra-low particulate delivery supports chip integrity and a < 0.05 EU/mL endotoxin release specification reduces the risk of inflammatory confounds in metabolic readouts.
Complete carbon source control
Add D-glucose, U-13C6-glucose, galactose, fructose, or no sugar. Combine with palmitate or other fatty acids. Define carbon source identity and concentration precisely for every experiment.
Dual buffering, understood on its own terms
This formulation carries both sodium bicarbonate and 25 mM HEPES. The bicarbonate concentration determines the recommended CO2 environment (see Technical Specifications); HEPES adds buffering capacity that helps limit pH drift during brief periods outside CO2 control, such as bench-top handling or short sampling steps.
Ultrapure-grade water
Formulated with Type 1 water (18.2 MΩ·cm), supporting a low trace-metal and organic-carbon background for sensitive metabolic assays.
Microchannel-safe purity
0.04 µm final filtration and a < 0.05 EU/mL endotoxin release specification help keep metabolic baselines free of particulate and endotoxin confounds.
Low background for imaging
This formulation does not include phenol red, avoiding phenol red's inherent optical absorbance. Combined with a low particulate baseline (0.04 µm final filtration), it supports confocal microscopy, TEER measurement, and biosensor OoC platforms.
Customization on demand
Custom glucose concentrations, carbon source additions, pH, and nutrient modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages, run as two prefilter-plus-final-filter pairs, reaching a final 0.04 µm polish. This matters for glucose-free metabolic assays, where particulate contamination and endotoxin can independently confound glycolytic and mitochondrial readouts.
-
1
0.1 µm Prefiltration I
Removes large particulates and aggregates; protects the first 0.04 µm final filter from early fouling.
-
2
0.04 µm Final filtration I
First 0.04 µm pass; retains sub-micron particulates and microaggregates that pass a standard 0.22 µm filter.
-
3
0.1 µm Prefiltration II
A second, dedicated prefilter protecting the second 0.04 µm cartridge — not a polish of Stage 2's effluent.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter prior to aseptic fill & finish.
Why filtration purity matters for metabolic assays
Subvisible particulates and elevated endotoxin can independently upregulate glycolytic signalling, confounding glucose uptake, lactate production, and oxygen consumption measurements. FluxMPS™ DCP-DMEMH-GPR1X targets both variables: a < 0.05 EU/mL endotoxin release specification and a validated 0.04 µm final filtration stage.
© Diagnocine® — DCP-DMEMH-GPR1X
Metabolic research and OoC applications
FluxMPS™ DCP-DMEMH-GPR1X is built for experiments where carbon source identity must be controlled — from Warburg-effect studies to 13C metabolic flux analysis and glucose dose-response studies on organ-on-a-chip platforms. Note: because this formulation contains sodium bicarbonate, it is not compatible with Agilent Seahorse XF assays, which require bicarbonate-free, phenol red-free medium; this product is phenol red-free but not bicarbonate-free. A bicarbonate-free custom formulation can be requested for Seahorse XF work.
Automated Bioreactors & Robotics
For continuous perfusion systems and robotic liquid handling, Diagnocine also offers an optional 0.01 µm (10 nm) ultra nano-filtered variant of this formulation — the separate MPS Grade tier described in the Grade note above — intended to further reduce particulate load in automated, valve-dense fluidic paths.
- Total Particulate Exclusion: extended nano-filtration for long-duration perfusion runs
- Valve & Sensor Protection: reduced particulate load in microvalves and inline sensors
- Extended Perfusion Stability: supports longer intervals between filter changes in closed-loop systems
Inquiry Required: the 0.01 µm MPS Grade variant is available by request. Contact support@diagnocine.com.
13C Metabolic Flux Analysis
Add U-13C6-glucose at any specific activity without background dilution from endogenous glucose. HEPES helps maintain pH during sample preparation outside the incubator.
Warburg Effect & OXPHOS Switching
Add glucose (Warburg), galactose (force OXPHOS), or no sugar (starvation) to study metabolic flexibility in cancer lines without a media change.
Glucose Dose-Response on Chip
Perfuse defined glucose gradients through OoC channels to study dose-dependent metabolic responses in endothelial, beta-cell, or hepatocyte chips.
iPSC Metabolic Maturation
Glucose-free base enables galactose-forced OXPHOS maturation protocols for iPSC-derived cardiomyocytes and hepatocytes.
Nutrient Deprivation Studies
Starvation experiments, glucose withdrawal, and nutrient re-feeding protocols with defined timing and concentration control.
Metabolic Imaging & Biosensors
Absence of phenol red and a low particulate baseline support confocal imaging, NAD(P)H imaging, glucose biosensors, and TEER measurement on metabolic chips.
Analytical release specifications
Every lot is released against the full specification matrix below. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] L-Glutamine, [+] Sodium Bicarbonate, [+] HEPES, [+] Calcium, [+] Magnesium | [-] Phenol Red, [-] Glucose, [-] Sodium Pyruvate |
| Appearance | Orange-colored, clear solution |
| Glucose | Not included — add at desired concentration |
| HEPES | 25 mM (5958 mg/L), pKa 7.3 at 37°C |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 310–350 mOsm/kg H2O |
| Total ingredients | 31 components across 4 formulation categories |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL (batch release specification) |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm/0.04 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, protect from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | ~10% CO2 recommended to balance 3700 mg/L sodium bicarbonate at pH 7.4; the 25 mM HEPES buffer adds stability during brief periods outside CO2 control |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
Glucose-free, pyruvate-free DMEM + HEPES scaffold: 31 ingredients across 4 formulation categories, verified per lot with CAS numbers. Glucose is intentionally absent — add your carbon source of choice. HEPES (25 mM = 5958 mg/L, CAS 7365-45-9) is listed under OTHERS.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Ferric nitrate nonahydrate | 7782-61-8 | 0.100 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium bicarbonate | 144-55-8 | 3700.000 |
| Sodium chloride | 7647-14-5 | 6400.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 109.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 30.000 |
| L-Arginine hydrochloride | 1119-34-2 | 84.000 |
| L-Cystine dihydrochloride | 30925-07-6 | 62.570 |
| L-Glutamine | 56-85-9 | 584.000 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 42.000 |
| L-Isoleucine | 73-32-5 | 105.000 |
| L-Leucine | 61-90-5 | 105.000 |
| L-Lysine hydrochloride | 657-27-2 | 146.000 |
| L-Methionine | 63-68-3 | 30.000 |
| L-Phenylalanine | 63-91-2 | 66.000 |
| L-Serine | 56-45-1 | 42.000 |
| L-Threonine | 72-19-5 | 95.000 |
| L-Tryptophan | 73-22-3 | 16.000 |
| L-Tyrosine Disodium Salt dihydrate | 69847-15-0 | 103.790 |
| L-Valine | 72-18-4 | 94.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 4.000 |
| D-Ca-Pantothenate | 137-08-6 | 4.000 |
| Folic acid | 59-30-3 | 4.000 |
| Nicotinamide | 98-92-0 | 4.000 |
| Pyridoxal hydrochloride | 65-22-5 | 4.000 |
| Riboflavin | 83-88-5 | 0.400 |
| Thiamine hydrochloride | 67-03-8 | 4.000 |
| i-Inositol | 87-89-8 | 7.200 |
| OTHERS | ||
| HEPES | 7365-45-9 | 5958.000 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system.
ISO 13485:2016 Quality Management
Manufactured under ISO 13485:2016-certified facilities. Final QA at the Diagnocine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm, supporting low trace-metal and organic-carbon background for metabolic flux measurements.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch, per-lot tested — no blending between batches; a Certificate of Analysis is issued for every lot.
Endotoxin — USP <85> BET
LAL assay, assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL.
Particulate — USP <788> Method 1
Light obscuration: NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).
Osmolality — USP <785>
Target: 310–350 mOsm/kg H2O.
Documentation & CoA
Full CoA with raw-material traceability available for every lot on request.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-DMEMH-GPR1X compares
FluxMPS™ DCP-DMEMH-GPR1X versus conventional glucose-free DMEM and standard DMEM for metabolic assays.
| Parameter | DCP-DMEMH-GPR1X (FluxMPS™) | Conventional GF-DMEM (0.22 µm filtered) | Standard DMEM (fixed glucose, 0.22 µm) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Conventional (not microfluidics rated) | Conventional (not microfluidics rated) |
| Glucose-free, pyruvate-free, phenol red-free DMEM + HEPES | check_circle Yes | cancel No | cancel No |
| Glucose content | None — researcher-defined | None | Fixed (1–4.5 g/L) |
| HEPES (25 mM) | check_circle Yes | Usually no | No |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (two 0.1/0.04 µm pairs) | 1 | 1 |
| Mycoplasma-retentive filtration | check_circle Yes (0.1/0.04 µm) | cancel No | cancel No |
| Endotoxin (release specification) | FluxMPS™ — < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> Method 1 particulate compliance | check_circle Yes | cancel Not specified | cancel Not specified |
| Water quality | Type 1, 18.2 MΩ·cm | Not specified | Not specified |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or none | ISO 9001 or none |
| Microfluidic channel compatibility | check_circle Yes | cancel Not validated | cancel Not validated |
| Custom formulation | check_circle Available | cancel Fixed | cancel Fixed |
Comparison figures from published supplier specifications, accessed 2 September 2026. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-DMEMH-GPR1X glucose-free DMEM + 25 mM HEPES.
Supporting literature
Key publications supporting glucose-free DMEM in metabolic flux analysis, isotope tracing, and organ-on-a-chip metabolic studies.
- Warburg O. On the origin of cancer cells. Science. 1956;123:309–314. doi:10.1126/science.123.3191.309
- Jain M, et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science. 2012;336:1040–1044. doi:10.1126/science.1218595
- Birsoy K, et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell. 2015;162:540–551. doi:10.1016/j.cell.2015.07.016
- Sullivan LB, et al. Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell. 2015;162:552–563. doi:10.1016/j.cell.2015.07.017
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Schell JC, et al. A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol Cell. 2014;56:400–413. doi:10.1016/j.molcel.2014.09.026
- Faubert B, et al. Lactate metabolism in human lung tumors. Cell. 2017;171:358–371. doi:10.1016/j.cell.2017.09.019
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x



